Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

67%

Ph phase_1

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

2(33.3%)

Phase 2Efficacy & side effects

4(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 12 (33.3%)

Phase 24 (66.7%)

Trials by Status

completed6100%

Recent Activity

0 active trials

Showing 5 of 6

completedphase_1

Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer

NCT04298333

completedphase_2

BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment

NCT03789019

completedphase_2

Clinical Trials (6)

Showing 6 of 6 trials

NCT04298333Phase 1

Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer

Completed

NCT03789019Phase 2

BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment

Completed

NCT02783794Phase 2

BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer

Completed

NCT03603197Phase 2

BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer

Completed

NCT01861509Phase 1

BP-C1 in Metastatic Breast Cancer Patients

Completed

NCT03627390Phase 2

BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6